Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells Via Inhibition of Cyclin-Dependent Kinase 6

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 May 21

PMID 32429317

Citations 33

Authors

Mohd Yousuf

Anas Shamsi

Parvez Khan

Mohd Shahbaaz

Mohamed F Alajmi

Afzal Hussain

Gulam Mustafa Hassan

Asimul Islam

Qazi Mohd Rizwanul Haque

Md Imtaiyaz Hassan

Affiliations

Soon will be listed here.

Abstract

Cyclin-Dependent Kinase 6 (CDK6) plays an important role in cancer progression, and thus, it is considered as an attractive drug target in anticancer therapeutics. This study presents an evaluation of dietary phytochemicals, capsaicin, tocopherol, rosmarinic acid, ursolic acid, ellagic acid (EA), limonene, caffeic acid, and ferulic acid for their potential to inhibit the activity of CDK6. Molecular docking and fluorescence binding studies revealed appreciable binding affinities of these compounds to the CDK6. Among them, EA shows the highest binding affinity for CDK6, and thus a molecular dynamics simulation study of 200 ns was performed to get deeper insights into the binding mechanism and stability of the CDK6-EA complex. Fluorescence binding studies revealed that EA binds to the CDK6 with a binding constant of = 10 M and subsequently inhibits its enzyme activity with an IC value of 3.053 µM. Analysis of thermodynamic parameters of CDK6-EA complex formation suggested a hydrophobic interaction driven process. The treatment of EA decreases the colonization of cancer cells and induces apoptosis. Moreover, the expression of CDK6 has been downregulated in EA-treated human breast cancer cell lines. In conclusion, this study establishes EA as a potent CDK6 inhibitor that can be further evaluated in CDK6 directed anticancer therapies.

Citing Articles

Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer.

Othman B, Beigh S, Albanghali M, Sindi A, Shanawaz M, Ibahim M Sci Rep. 2025; 15(1):5426.

PMID: 39948091 PMC: 11825887. DOI: 10.1038/s41598-024-84401-4.

Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products.

Debnath A, Mazumder R, Singh A, Singh R PLoS One. 2025; 20(1):e0313830.

PMID: 39813224 PMC: 11734976. DOI: 10.1371/journal.pone.0313830.

Research progress on the anti-tumor effects of euphorbia humifusa.

Zhao X, Zhang C, Qian X, Zhang J, Wang G, Wang Z Discov Oncol. 2024; 15(1):761.

PMID: 39692814 PMC: 11655944. DOI: 10.1007/s12672-024-01624-7.

Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors.

Hawash M Cells. 2024; 13(19.

PMID: 39404419 PMC: 11476325. DOI: 10.3390/cells13191656.

Anti-tumor Effects of Polyphenols via Targeting Cancer Driving Signaling Pathways: A Review.

Moar K, Yadav S, Pant A, Deepika , Maurya P Indian J Clin Biochem. 2024; 39(4):470-488.

PMID: 39346722 PMC: 11436542. DOI: 10.1007/s12291-024-01222-y.

References

Shamsi A, Shahwan M, Ahamad S, Hassan M, Ahmad F, Islam A . Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer's drug donepezil with human transferrin: implications of Alzheimer's drug. J Biomol Struct Dyn. 2019; 38(4):1094-1102. DOI: 10.1080/07391102.2019.1595728. View

Yun D, Kang Y, Yun B, Kim E, Kim M, Park J . Distinctive Metabolism of Flavonoid between Cultivated and Semiwild Soybean Unveiled through Metabolomics Approach. J Agric Food Chem. 2016; 64(29):5773-83. DOI: 10.1021/acs.jafc.6b01675. View

Anand U, Jash C, Boddepalli R, Shrivastava A, Mukherjee S . Exploring the mechanism of fluorescence quenching in proteins induced by tetracycline. J Phys Chem B. 2011; 115(19):6312-20. DOI: 10.1021/jp2008978. View

Shamsi A, Ahmed A, Bano B . Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight. J Biomol Struct Dyn. 2017; 36(6):1479-1489. DOI: 10.1080/07391102.2017.1326320. View

Gupta P, Khan F, Roy S, Anwar S, Dahiya R, Alajmi M . Functional implications of pH-induced conformational changes in the Sphingosine kinase 1. Spectrochim Acta A Mol Biomol Spectrosc. 2019; 225:117453. DOI: 10.1016/j.saa.2019.117453. View

Han D, Lee M, Kim J . Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res. 2006; 26(5A):3601-6. View

Wang H, Nicolay B, Chick J, Gao X, Geng Y, Ren H . The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature. 2017; 546(7658):426-430. PMC: 5516959. DOI: 10.1038/nature22797. View

Shapiro G . Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol. 2006; 24(11):1770-83. DOI: 10.1200/JCO.2005.03.7689. View

Jacobson M, Friesner R, Xiang Z, Honig B . On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol. 2002; 320(3):597-608. DOI: 10.1016/s0022-2836(02)00470-9. View

10.

Shamsi A, Ahmed A, Khan M, Husain F, Amani S, Bano B . Investigating the interaction of anticancer drug temsirolimus with human transferrin: Molecular docking and spectroscopic approach. J Mol Recognit. 2018; 31(10):e2728. DOI: 10.1002/jmr.2728. View

11.

Domitrovic R, Skoda M, Vasiljev Marchesi V, Cvijanovic O, Pernjak Pugel E, Stefan M . Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice. Food Chem Toxicol. 2012; 51:370-8. DOI: 10.1016/j.fct.2012.10.021. View

12.

Chi Z, Liu R . Phenotypic characterization of the binding of tetracycline to human serum albumin. Biomacromolecules. 2010; 12(1):203-9. DOI: 10.1021/bm1011568. View

13.

Manning G, Whyte D, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science. 2002; 298(5600):1912-34. DOI: 10.1126/science.1075762. View

14.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

15.

Shamsi A, Mohammad T, Khan M, Shahwan M, Husain F, Rehman M . Unraveling Binding Mechanism of Alzheimer's Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases. Biomolecules. 2019; 9(9). PMC: 6770857. DOI: 10.3390/biom9090495. View

16.

McCubrey J, Steelman L, Chappell W, Abrams S, Wong E, Chang F . Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2006; 1773(8):1263-84. PMC: 2696318. DOI: 10.1016/j.bbamcr.2006.10.001. View

17.

Zielkiewicz J . Structural properties of water: comparison of the SPC, SPCE, TIP4P, and TIP5P models of water. J Chem Phys. 2005; 123(10):104501. DOI: 10.1063/1.2018637. View

18.

Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R . GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013; 29(7):845-54. PMC: 3605599. DOI: 10.1093/bioinformatics/btt055. View

19.

Gulzar M, Ali S, Khan F, Khan P, Taneja P, Hassan M . Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies. J Biomol Struct Dyn. 2018; 37(16):4327-4337. DOI: 10.1080/07391102.2018.1546621. View

20.

Kastan M, Bartek J . Cell-cycle checkpoints and cancer. Nature. 2004; 432(7015):316-23. DOI: 10.1038/nature03097. View